Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
Akamai Technologies, Inc. · AKAM · FY2024 Q2 · Calendar Q3 2024
The supplied analysis supports a constructive but qualified view: security and compute growth, cross-selling, and edge-cloud investment are offsetting delivery weakness, while execution, competition, FX, and integration remain important tests.
Research this report with FN2. Free to start; review your question before sending.
Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Compared with the prior quarter, the analysis shifts from lowered guidance and the planned NoName acquisition to maintained guidance, a completed NoName acquisition, continued security and compute growth, and a stated increase in capex for compute expansion.
Management maintained guidance; the supplied analysis cites Q3 revenue guidance of $988–1,008 million and full-year revenue growth of 4–5%, with operating margins near 29%.
Follow AKAM with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 free1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Nov 16, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | In Line | Outperform | Downgrade | Nov 11, 2026 |
| Baird | Neutral | Neutral | Maintain | Nov 9, 2026 |
| UBS | Neutral | Neutral | Maintain | Nov 6, 2026 |
| Susquehanna | Positive | Positive | Maintain | Nov 6, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Nov 6, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Nov 6, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Nov 6, 2026 |
| DA Davidson | Buy | Buy | Maintain | Nov 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 2, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 21, 2026 |
| Raymond James | Strong Buy | Outperform | Upgrade | Oct 20, 2026 |
| TD Cowen | Hold | Hold | Maintain | Sep 25, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Sep 25, 2026 |
| Guggenheim | Buy | Buy | Maintain | Sep 25, 2026 |
| B of A Securities | Buy | Buy | Maintain | Sep 25, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Sep 4, 2026 |
| HSBC | Hold | Buy | Downgrade | Aug 10, 2026 |
| Needham | Hold | Hold | Maintain | Feb 21, 2025 |
| Oppenheimer | Outperform | Perform | Upgrade | Dec 2, 2024 |
| Tigress Financial | Strong Buy | Strong Buy | Maintain | Aug 29, 2024 |
| Craig-Hallum | Buy | Hold | Upgrade | Aug 9, 2024 |
| CFRA | Hold | Hold | Maintain | May 24, 2023 |
| Loop Capital | Hold | Hold | Maintain | Mar 1, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 15, 2023 |
| Truist Securities | Buy | Buy | Maintain | Aug 10, 2022 |
| FBN Securities | Outperform | Outperform | Maintain | Aug 10, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 10, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 29, 2020 |
| B. Riley Securities | Buy | Buy | Maintain | Apr 29, 2020 |
| B. Riley FBR | Buy | Buy | Maintain | Apr 29, 2020 |
| Nomura Instinet | Neutral | Neutral | Maintain | Apr 15, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 15, 2020 |
| Goldman Sachs | Neutral | Sell | Upgrade | Mar 26, 2020 |
| B. Riley | Buy | Buy | Maintain | Feb 12, 2020 |
| Deutsche Bank | Sell | Hold | Downgrade | Mar 25, 2019 |
| MKM Partners | Buy | Buy | Maintain | Jun 27, 2018 |
| Wells Fargo | Market Perform | Market Perform | Maintain | Oct 25, 2017 |
| Drexel Hamilton | Buy | Buy | Maintain | Mar 21, 2017 |
| FBR Capital | Market Perform | Underperform | Upgrade | Oct 26, 2016 |
| Pacific Crest | Overweight | Downgrade | Jul 27, 2016 | |
| Stifel Nicolaus | Hold | Hold | Maintain | Mar 24, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Nov 3, 2015 |
| Canaccord Genuity | Hold | Hold | Maintain | Oct 28, 2015 |
| JMP Securities | Market Outperform | Market Perform | Upgrade | Aug 28, 2015 |
| Jefferies | Hold | Hold | Maintain | May 2, 2014 |
| Maxim Group | Buy | Buy | Maintain | Mar 15, 2013 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Feb 7, 2013 |
| Janney Capital | Neutral | Buy | Downgrade | Feb 7, 2013 |
| Oxen Group | Hold | Hold | Maintain | Mar 14, 2012 |
| Stifel | Buy | Buy | Maintain | Feb 9, 2012 |
| PiperJaffray | Neutral | Neutral | Maintain | Feb 9, 2012 |
Upside is calculated against the persisted previous close $85.4. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| FBN Securities | Shebly Seyrafi | $120 | $84.2 | +40.5% | Nov 6, 2026 |
| KeyBanc | Jackson Ader | $175 | $84.11 | +104.9% | Nov 6, 2026 |
| RBC Capital | Rishi Jaluria | $85 | $84.62 | -0.5% | Nov 6, 2026 |
| UBS | Roger Boyd | $90 | $77.84 | +5.4% | Nov 6, 2026 |
| Evercore ISI | Peter Levine | $150 | $77.84 | +75.6% | Nov 6, 2026 |
| Morgan Stanley | Sanjit Singh | $149 | $92.72 | +74.5% | Nov 2, 2026 |
| UBS | Analyst unavailable | $100 | $90.51 | +17.1% | Oct 22, 2026 |
| Piper Sandler | Analyst unavailable | $120 | $89.63 | +40.5% | Oct 21, 2026 |
| Raymond James | Frank Louthan | $170 | $108.99 | +99.1% | Sep 29, 2026 |
| D.A. Davidson | Rudy Kessinger | $150 | $113.33 | +75.6% | Sep 28, 2026 |
| Piper Sandler | Analyst unavailable | $158 | $110.41 | +85.0% | Sep 25, 2026 |
| Guggenheim | John DiFucci | $225 | $110.41 | +163.5% | Sep 25, 2026 |
| UBS | Roger Boyd | $148 | $110.41 | +73.3% | Sep 25, 2026 |
| Piper Sandler | Analyst unavailable | $125 | $108.62 | +46.4% | Aug 31, 2026 |
| HSBC | Stephen Bersey | $123 | $110.54 | +44.0% | Aug 10, 2026 |
| Robert W. Baird | Analyst unavailable | $140 | $113.88 | +63.9% | Aug 7, 2026 |
| RBC Capital | Analyst unavailable | $135 | $114.89 | +58.1% | Aug 7, 2026 |
| UBS | Roger Boyd | $125 | $111.79 | +46.4% | Jul 29, 2026 |
| Evercore ISI | Peter Levine | $175 | $113.3 | +104.9% | Jul 27, 2026 |
| Morgan Stanley | Sanjit Singh | $165 | $161.14 | +93.2% | May 14, 2026 |
| Susquehanna | Shyam Patil | $175 | $147.71 | +104.9% | May 11, 2026 |
| Scotiabank | Patrick Colville | $180 | $141.92 | +110.8% | May 8, 2026 |
| UBS | Analyst unavailable | $160 | $141.46 | +87.4% | May 8, 2026 |
| Robert W. Baird | Analyst unavailable | $150 | $140.3 | +75.6% | May 8, 2026 |
| Oppenheimer | Analyst unavailable | $180 | $140.73 | +110.8% | May 8, 2026 |
| D.A. Davidson | Analyst unavailable | $185 | $135.3 | +116.6% | May 8, 2026 |
| Raymond James | Analyst unavailable | $140 | $135.93 | +63.9% | May 8, 2026 |
| Evercore ISI | Analyst unavailable | $165 | $133.5 | +93.2% | May 8, 2026 |
| Craig-Hallum | Analyst unavailable | $190 | $116.69 | +122.5% | May 8, 2026 |
| KeyBanc | Jackson Ader | $195 | $116.69 | +128.3% | May 8, 2026 |
| Raymond James | Frank Louthan | $120 | $105.47 | +40.5% | Mar 12, 2026 |
| Raymond James | Frank Louthan | $100 | $99.02 | +17.1% | Feb 23, 2026 |
| Goldman Sachs | Analyst unavailable | $76 | $94.17 | -11.0% | Feb 23, 2026 |
| Piper Sandler | Analyst unavailable | $97 | $94.17 | +13.6% | Feb 23, 2026 |
| Scotiabank | Patrick Colville | $120 | $99.42 | +40.5% | Feb 20, 2026 |
| Susquehanna | Analyst unavailable | $120 | $98.89 | +40.5% | Feb 20, 2026 |
| Evercore ISI | Analyst unavailable | $115 | $99.26 | +34.7% | Feb 20, 2026 |
| Robert W. Baird | Analyst unavailable | $110 | $109.59 | +28.8% | Feb 20, 2026 |
| UBS | Roger Boyd | $110 | $109.59 | +28.8% | Feb 20, 2026 |
| KeyBanc | Analyst unavailable | $120 | $109.59 | +40.5% | Feb 20, 2026 |
| Morgan Stanley | Sanjit Singh | $120 | $109.59 | +40.5% | Feb 20, 2026 |
| Oppenheimer | Analyst unavailable | $115 | $92.68 | +34.7% | Feb 5, 2026 |
| Morgan Stanley | Analyst unavailable | $115 | $88.12 | +34.7% | Jan 12, 2026 |
| Scotiabank | Analyst unavailable | $105 | $87.36 | +23.0% | Jan 9, 2026 |
| Piper Sandler | James Fish | $89 | $85.1 | +4.2% | Jan 5, 2026 |
| KeyBanc | Jackson Ader | $115 | $85.89 | +34.7% | Dec 15, 2025 |
| Oppenheimer | Analyst unavailable | $100 | $87.17 | +17.1% | Nov 17, 2025 |
| Piper Sandler | James Fish | $83 | $70.53 | -2.8% | Aug 8, 2025 |
| Morgan Stanley | Analyst unavailable | $85 | $73.65 | -0.5% | Aug 5, 2025 |
| Morgan Stanley | Keith Weiss | $90 | $73.81 | +5.4% | Apr 16, 2025 |
| Robert W. Baird | William Power | $115 | $101.02 | +34.7% | Nov 11, 2024 |
| HSBC | Stephen Bersey | $121 | $101.02 | +41.7% | Nov 11, 2024 |
| Scotiabank | Patrick Colville | $115 | $91.57 | +34.7% | Aug 9, 2024 |
| Craig-Hallum | Jeff Van Rhee | $125 | $91.57 | +46.4% | Aug 9, 2024 |
| RBC Capital | Mark Mahaney | $100 | $91.57 | +17.1% | Aug 9, 2024 |
| Guggenheim | Raymond McDonough | $128 | $96.97 | +49.9% | Jul 29, 2024 |
| HSBC | Stephen Bersey | $96 | $96.37 | +12.4% | Jul 24, 2024 |
| Piper Sandler | James Fish | $112 | $95.14 | +31.1% | Jul 15, 2024 |
| Scotiabank | Patrick Colville | $110 | $92.22 | +28.8% | Jul 8, 2024 |
| Susquehanna | Shyam Patil | $135 | $92.86 | +58.1% | May 10, 2024 |
| Piper Sandler | James Fish | $114 | $94.39 | +33.5% | May 10, 2024 |
| KeyBanc | Thomas Blakey | $119 | $94.48 | +39.3% | May 10, 2024 |
| D.A. Davidson | Rudy Kessinger | $125 | $101.44 | +46.4% | May 7, 2024 |
| Piper Sandler | James Fish | $136 | $105.82 | +59.3% | Apr 9, 2024 |
| Robert W. Baird | William Power | $135 | $110.16 | +58.1% | Mar 7, 2024 |
| Guggenheim | Ramond McDonnough | $75 | $78.66 | -12.2% | Feb 16, 2023 |
| Loop Capital Markets | Analyst unavailable | $91 | $87.49 | +6.6% | Feb 7, 2023 |
| Morgan Stanley | Keith Weiss | $102 | $95.81 | +19.4% | Aug 10, 2022 |
| Truist Financial | Analyst unavailable | $125 | $95.98 | +46.4% | Aug 10, 2022 |
| Morgan Stanley | Analyst unavailable | $102 | $92.26 | +19.4% | Aug 10, 2022 |
| RBC Capital | Analyst unavailable | $110 | $95.08 | +28.8% | Aug 10, 2022 |
| Morgan Stanley | Analyst unavailable | $110 | $90.65 | +28.8% | Jul 11, 2022 |
| Piper Sandler | Analyst unavailable | $102 | $93.13 | +19.4% | Jul 6, 2022 |
| Morgan Stanley | Analyst unavailable | $118 | $100.74 | +38.2% | May 4, 2022 |
| Piper Sandler | James Fish | $126 | $116.7 | +47.5% | Apr 25, 2022 |
| Tigress Financial | Ivan Feinseth | $168 | $109.94 | +96.7% | Jan 26, 2022 |
| KeyBanc | Thomas Blakey | $140 | $112.08 | +63.9% | Jan 18, 2022 |
| Morgan Stanley | Keith Weiss | $130 | $110.87 | +52.2% | Nov 3, 2021 |
| Truist Financial | Gregory P Miller | $140 | $105.13 | +63.9% | Nov 2, 2021 |
Track every rating change on AKAM the moment it posts. Free to start.
Start freeAkamai Technologies, Inc. (AKAM) is a leading global provider of cloud services, specializing in the secure delivery, optimization, and protection of online content and business applications across the internet. The company's primary focus involves offering sophisticated cloud-based solutions designed to shield digital infrastructure, websites, applications (including APIs), and end-users from a wide array of cyberattacks and online threats, all while simultaneously enhancing performance. Akamai further excels in accelerating web and mobile experiences, facilitating dynamic and highly responsive websites and applications.…
| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CBRS Cerebras Systems Inc. | FY2026 Q3 · Calendar Q4 2026 | -333.5% | -3.3% | Cerebras Q3 revenue rose 70%; capacity and deal timing remain key tests |
| NBIS Nebius Group N.V. | FY2026 Q3 · Calendar Q4 2026 | +141.5% | -16.8% | Nebius Q3: AI cloud growth accelerates as capacity spending rises |
| AMAT Applied Materials, Inc. | FY2026 Q4 · Calendar Q4 2026 | +2.5% | -3.6% | Applied Materials: AI demand supports growth, capacity is the constraint |
| CSCO Cisco Systems, Inc. | FY2027 Q1 · Calendar Q4 2026 | +5.3% | +1.2% | Cisco raises FY27 outlook as AI networking demand accelerates |
| GIB CGI Inc. | FY2026 Q4 · Calendar Q4 2026 | +0.6% | -1.7% | CGI Q4 FY2026: Backlog and bookings support measured growth |
| CRWV CoreWeave, Inc. Class A Common Stock | FY2026 Q3 · Calendar Q4 2026 | 0.0% | -0.5% | CoreWeave Q3: 168% Revenue Growth, Higher FY2026 Guidance |
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-24. For educational purposes only; not investment advice.